These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 26891331
1. Impact of DCC (rs714) and PSCA (rs2294008 and rs2976392) Gene Polymorphism in Modulating Cancer Risk in Asian Population. Chandra V, Kim JJ, Gupta U, Mittal B, Rai R. Genes (Basel); 2016 Feb 16; 7(2):. PubMed ID: 26891331 [Abstract] [Full Text] [Related]
2. The PSCA polymorphisms derived from genome-wide association study are associated with risk of gastric cancer: a meta-analysis. Shi D, Wang S, Gu D, Wu D, Wang M, Chu H, Tong N, Ma L, Zhong D, Zhang Z. J Cancer Res Clin Oncol; 2012 Aug 16; 138(8):1339-45. PubMed ID: 22481254 [Abstract] [Full Text] [Related]
3. The PSCA rs2294008 (C/T) Polymorphism Increases the Risk of Gastric and Bladder Cancer: A Meta-Analysis. Wang XF, Liu DL, Geng L. Genet Test Mol Biomarkers; 2023 Feb 16; 27(2):44-55. PubMed ID: 36853840 [Abstract] [Full Text] [Related]
6. Impact of PSCA gene polymorphisms in modulating gastric cancer risk in the Chinese population. Yan K, Wu K, Lin C, Jie Z. Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31416884 [Abstract] [Full Text] [Related]
8. PSCA s2294008 C>T and rs2976392 G>A polymorphisms contribute to cancer susceptibility: evidence from published studies. Gu Y, Dai QS, Hua RX, Zhang B, Zhu JH, Huang JW, Xie BH, Xiong SQ, Tan GS, Li HP. Genes Cancer; 2015 May 30; 6(5-6):254-264. PubMed ID: 26124924 [Abstract] [Full Text] [Related]
10. Genetic Susceptibility of DCC Gene in Gallbladder Cancer in Kashmir and Meta-Analysis. Malik MA, Malik SA, Haq MG, Bangri SA, Ahmad SZ, Shah OJ, Shah ZA. Nutr Cancer; 2022 May 30; 74(3):947-955. PubMed ID: 34259111 [Abstract] [Full Text] [Related]
11. PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese population. Qiu LX, Cheng L, He J, Zhou ZR, Wang MY, Zhou F, Guo WJ, Li J, Sun MH, Zhou XY, Wang YN, Yang YJ, Wang JC, Jin L, Zhu XD, Wei QY. Oncotarget; 2016 Feb 23; 7(8):9420-8. PubMed ID: 26848528 [Abstract] [Full Text] [Related]
17. Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population. Wang S, Tang J, Wang M, Yuan L, Zhang Z. Carcinogenesis; 2010 Apr 23; 31(4):621-4. PubMed ID: 20083643 [Abstract] [Full Text] [Related]
18. Association of a common genetic variant in prostate stem cell antigen with cancer risk. Zuo L, Zhang LF, Wu XP, Zhou ZX, Zou JG, He J, Hou JQ. Arch Med Sci; 2014 Jun 29; 10(3):425-33. PubMed ID: 25097570 [Abstract] [Full Text] [Related]
19. Contribution of prostate stem cell antigen variation rs2294008 to the risk of bladder cancer. Deng S, Ren ZJ, Jin T, Yang B, Dong Q. Medicine (Baltimore); 2019 Apr 29; 98(16):e15179. PubMed ID: 31008939 [Abstract] [Full Text] [Related]
20. Effects of PSCA rs2294008 (C/T) and c-MYC rs9642880 (G/T) polymorphisms on bladder cancer: evidence from a meta-analysis. Gao J, Yang PT, Diao Y, Kang HF, Zhao Y, Lin S, Wang ZM, Wang M, Wang XJ, Dai ZJ. Int J Clin Exp Med; 2015 Apr 29; 8(2):2156-64. PubMed ID: 25932146 [Abstract] [Full Text] [Related] Page: [Next] [New Search]